Summary
Commonly reported side effects of bosutinib include: diarrhea, abdominal pain, anemia, edema, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, nausea, neutropenia, peripheral edema, thrombocytopenia, and vomiting. Continue reading for a comprehensive list of adverse effects.
Applies to bosutinib: oral tablet.
Serious side effects of Bosutinib
Along with its needed effects, bosutinib may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking bosutinib:
More common
- Black, tarry stools
- bleeding gums
- blood in the urine or stools
- chills
- cough
- difficult or labored breathing
- fever
- lower back or side pain
- painful or difficult urination
- pale skin
- pinpoint red spots on the skin
- sore throat
- swelling of the hands, ankles, feet, or lower legs
- tightness in the chest
- troubled breathing with exertion
- ulcers, sores, or white spots in the mouth
- unusual bleeding or bruising
- unusual tiredness or weakness
Less common
- Agitation
- chest pain or discomfort
- clay-colored stools
- cough with mucus
- confusion
- dark urine
- decreased appetite
- decreased urination
- depression
- diarrhea
- dizziness
- dry mouth
- fainting
- fast or irregular heartbeat
- general feeling of discomfort or illness
- headache
- hives, itching, or skin rash
- hoarseness
- hostility
- increased sweating
- increased thirst
- irritation
- joint pain, stiffness or swelling
- lightheadedness
- loss of appetite
- muscle aches, pains, or twitching
- nausea
- numbness or tingling in the hands, feet, or lips
- rapid breathing
- rapid weight gain
- redness of the skin
- runny nose
- seizures
- shivering
- sneezing
- stomach pain or tenderness
- sunken eyes
- swelling of the eyelids, face, lips, hands, or feet
- thirst
- trouble sleeping
- trouble swallowing
- vomiting
- weakness or heaviness of the legs
- wrinkled skin
Rare
- Blistering, peeling, or loosening of the skin
- bloating
- blue lips, fingernails, or skin
- chest pain, possibly moving to the left arm, neck, or shoulder
- constipation
- coughing that sometimes produces a pink frothy sputum
- difficult, noisy breathing
- indigestion
- irregular, fast or slow, or shallow breathing
- pains in the stomach, side, or abdomen, possibly radiating to the back
- puffiness or swelling of the eyelids or around the eyes, face, lips or tongue
- red, irritated eyes
- vomiting of blood or material that looks like coffee grounds
- yellow eyes or skin
Other side effects of Bosutinib
Some side effects of bosutinib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Back pain
- difficulty with moving
- lack or loss of strength
- muscle stiffness
- stuffy nose
Less common
- Blemishes on the skin
- burning feeling in the chest or stomach
- change in taste
- hearing loss
- loss of taste
- muscle cramping
- pimples
- ringing, buzzing, or other unexplained noise in the ears that continues
- stomach upset
Rare
- Flaking and falling off of the skin
For Healthcare Professionals
Applies to bosutinib: oral tablet.
General
The most commonly reported side effects were diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, and fatigue.[Ref]
Cardiovascular
Common (1% to 10%): Pericardial effusion, chest pain, prolonged QT interval
Uncommon (0.1% to 1%): Pericarditis[Ref]
Hematologic
Very common (10% or more): Low platelet count (less than 50 × 10(9)/L, up to 57%), thrombocytopenia (up to 40%), absolute neutrophil count (less than 1 × 10(9)/L, up to 37%), Low hemoglobin (less than 80 g/L, up to 35%), anemia (up to 27%), neutropenia (16%), leukopenia (11%)
Common (1% to 10%): Febrile neutropenia
Uncommon (0.1% to 1%): Granulocytopenia
Frequency not reported: Myelosuppression[Ref]
Hepatic
Very common (10% or more): Increased alanine aminotransferase (up to 22%), increased aspartate aminotransferase (up to 18%)
Common (1% to 10%): Increased bilirubin [greater than 3 times the upper limit of normal (3 x ULN)], hepatotoxicity, abnormal hepatic function, increased gamma-glutamyltransferase
Uncommon (0.1% to 1%): Liver injury
Frequency not reported: Hepatic toxicity[Ref]
Gastrointestinal
Very common (10% or more): Diarrhea (up to 84%), nausea (up to 46%), abdominal pain (up to 40%), vomiting (up to 37%)
Common (1% to 10%): Increased lipase (greater than 2 × ULN), gastritis, increased blood amylase
Uncommon (0.1% to 1%): Acute pancreatitis, gastrointestinal hemorrhage
Frequency not reported: Gastrointestinal toxicity[Ref]
Dermatologic
Very common (10% or more): Rash (up to 34%), pruritus (up to 11%)
Common (1% to 10%): Urticaria, pruritus, acne
Uncommon (0.1% to 1%): Erythema multiforme, exfoliative rash, drug eruption[Ref]
Hypersensitivity
Common (1% to 10%): Drug hypersensitivity
Uncommon (0.1% to 1%): Anaphylactic shock[Ref]
Respiratory
Very common (10% or more): Cough (up to 20%), nasopharyngitis (up to 12%), respiratory tract infection (up to 12%), dyspnea (up to 10%)
Common (1% to 10%): Pneumonia, influenza, bronchitis, pleural effusion
Uncommon (0.1% to 1%): Acute pulmonary edema, respiratory failure, pulmonary hypertension[Ref]
Metabolic
Very common (10% or more): Decreased appetite (up to 13%)
Common (1% to 10%): Hyperkalemia, dehydration
Frequency not reported: Fluid retention[Ref]
Musculoskeletal
Very common (10% or more): Arthralgia (up to 14%), back pain (up to 12%)
Common (1% to 10%): Myalgia[Ref]
Nervous system
Very common (10% or more): Headache (up to 20%), dizziness (up to 10%)
Common (1% to 10%): Dysgeusia[Ref]
Other
Very common (10% or more): Fatigue (up to 26%), pyrexia (up to 22%), edema (up to 14%), asthenia (11%)
Common (1% to 10%): Low phosphorus (less than 0.6 mmol/L), tinnitus, pain, increased blood creatine phosphokinase[Ref]
Renal
Common (1% to 10%): Increased blood creatinine
Uncommon (0.1% to 1%): Acute renal failure, renal failure, renal impairment[Ref]